APO Research
Talk to an analyst

APO RESEARCH · REPORT

Osimertinib Generics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Osimertinib Generics Market Analysis and Forecast 2026-2032

27 December 2025194 pages

Choose your research edition.

Industry ResearchOsimertinib Generics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Osimertinib Generics Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Osimertinib Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Osimertinib Generics Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Osimertinib Generics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Osimertinib Generics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Osimertinib Generics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Osimertinib Generics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Osimertinib Generics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Osimertinib Generics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Osimertinib Generics include Beacon, Drug International, General Pharmaceuticals, Pharmacil, Zydus and Wanbang Biopharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Osimertinib Generics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Osimertinib Generics, also provides the sales of main regions and countries. Of the upcoming market potential for Osimertinib Generics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Osimertinib Generics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Osimertinib Generics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Osimertinib Generics sales, projected growth trends, production technology, application and end-user industry.

Osimertinib Generics Segment by Company

Beacon

Drug International

General Pharmaceuticals

Pharmacil

Zydus

Wanbang Biopharmaceuticals

Osimertinib Generics Segment by Type

40mg per Tablet

80mg per Tablet

Osimertinib Generics Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Osimertinib Generics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Osimertinib Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Osimertinib Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Osimertinib Generics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Osimertinib Generics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Osimertinib Generics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Osimertinib Generics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Osimertinib Generics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 40mg per Tablet Major Manufacturers Table 3. 80mg per Tablet Major Manufacturers Table 4. Global Osimertinib Generics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital and Clinic Major Manufacturers Table 6. Retail Pharmacies Major Manufacturers Table 7. Other Major Manufacturers Table 8. Osimertinib Generics Industry Trends Table 9. Osimertinib Generics Industry Drivers Table 10. Osimertinib Generics Industry Opportunities and Challenges Table 11. Osimertinib Generics Industry Restraints Table 12. Global Osimertinib Generics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Osimertinib Generics Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Osimertinib Generics Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Osimertinib Generics Revenue Market Share by Region (2021-2026) Table 16. Global Osimertinib Generics Revenue Market Share by Region (2027-2032) Table 17. Global Osimertinib Generics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Osimertinib Generics Sales by Region (2021-2026) & (K Units) Table 19. Global Osimertinib Generics Sales by Region (2027-2032) & (K Units) Table 20. Global Osimertinib Generics Sales Market Share by Region (2021-2026) Table 21. Global Osimertinib Generics Sales Market Share by Region (2027-2032) Table 22. Global Osimertinib Generics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Osimertinib Generics Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Osimertinib Generics Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Osimertinib Generics Sales Market Share by Manufacturers (2021-2026) Table 26. Global Osimertinib Generics Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Osimertinib Generics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Osimertinib Generics Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Osimertinib Generics Manufacturers, Product Type & Application Table 30. Global Osimertinib Generics Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Osimertinib Generics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Osimertinib Generics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Osimertinib Generics Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Osimertinib Generics Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Osimertinib Generics Revenue Market Share by Type (2021-2026) Table 37. Global Osimertinib Generics Revenue Market Share by Type (2027-2032) Table 38. Global Osimertinib Generics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Osimertinib Generics Sales by Type (2021-2026) & (K Units) Table 40. Global Osimertinib Generics Sales by Type (2027-2032) & (K Units) Table 41. Global Osimertinib Generics Sales Market Share by Type (2021-2026) Table 42. Global Osimertinib Generics Sales Market Share by Type (2027-2032) Table 43. Global Osimertinib Generics Price by Type (2021-2026) & (US$/Unit) Table 44. Global Osimertinib Generics Price by Type (2027-2032) & (US$/Unit) Table 45. Global Osimertinib Generics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Osimertinib Generics Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Osimertinib Generics Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Osimertinib Generics Revenue Market Share by Application (2021-2026) Table 49. Global Osimertinib Generics Revenue Market Share by Application (2027-2032) Table 50. Global Osimertinib Generics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Osimertinib Generics Sales by Application (2021-2026) & (K Units) Table 52. Global Osimertinib Generics Sales by Application (2027-2032) & (K Units) Table 53. Global Osimertinib Generics Sales Market Share by Application (2021-2026) Table 54. Global Osimertinib Generics Sales Market Share by Application (2027-2032) Table 55. Global Osimertinib Generics Price by Application (2021-2026) & (US$/Unit) Table 56. Global Osimertinib Generics Price by Application (2027-2032) & (US$/Unit) Table 57. Beacon Company Information Table 58. Beacon Business Overview Table 59. Beacon Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Beacon Osimertinib Generics Product Portfolio Table 61. Beacon Recent Development Table 62. Drug International Company Information Table 63. Drug International Business Overview Table 64. Drug International Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Drug International Osimertinib Generics Product Portfolio Table 66. Drug International Recent Development Table 67. General Pharmaceuticals Company Information Table 68. General Pharmaceuticals Business Overview Table 69. General Pharmaceuticals Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. General Pharmaceuticals Osimertinib Generics Product Portfolio Table 71. General Pharmaceuticals Recent Development Table 72. Pharmacil Company Information Table 73. Pharmacil Business Overview Table 74. Pharmacil Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Pharmacil Osimertinib Generics Product Portfolio Table 76. Pharmacil Recent Development Table 77. Zydus Company Information Table 78. Zydus Business Overview Table 79. Zydus Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Zydus Osimertinib Generics Product Portfolio Table 81. Zydus Recent Development Table 82. Wanbang Biopharmaceuticals Company Information Table 83. Wanbang Biopharmaceuticals Business Overview Table 84. Wanbang Biopharmaceuticals Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Wanbang Biopharmaceuticals Osimertinib Generics Product Portfolio Table 86. Wanbang Biopharmaceuticals Recent Development Table 87. North America Osimertinib Generics Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Osimertinib Generics Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Osimertinib Generics Sales by Type (2021-2026) & (K Units) Table 90. North America Osimertinib Generics Sales by Type (2027-2032) & (K Units) Table 91. North America Osimertinib Generics Sales Price by Type (2021-2026) & (US$/Unit) Table 92. North America Osimertinib Generics Sales Price by Type (2027-2032) & (US$/Unit) Table 93. North America Osimertinib Generics Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Osimertinib Generics Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Osimertinib Generics Sales by Application (2021-2026) & (K Units) Table 96. North America Osimertinib Generics Sales by Application (2027-2032) & (K Units) Table 97. North America Osimertinib Generics Sales Price by Application (2021-2026) & (US$/Unit) Table 98. North America Osimertinib Generics Sales Price by Application (2027-2032) & (US$/Unit) Table 99. North America Osimertinib Generics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Osimertinib Generics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Osimertinib Generics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Osimertinib Generics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 103. North America Osimertinib Generics Sales by Country (2021-2026) & (K Units) Table 104. North America Osimertinib Generics Sales by Country (2027-2032) & (K Units) Table 105. North America Osimertinib Generics Sales Price by Country (2021-2026) & (US$/Unit) Table 106. North America Osimertinib Generics Sales Price by Country (2027-2032) & (US$/Unit) Table 107. United States Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 108. Canada Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 109. Mexico Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 110. Europe Osimertinib Generics Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Osimertinib Generics Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Osimertinib Generics Sales by Type (2021-2026) & (K Units) Table 113. Europe Osimertinib Generics Sales by Type (2027-2032) & (K Units) Table 114. Europe Osimertinib Generics Sales Price by Type (2021-2026) & (US$/Unit) Table 115. Europe Osimertinib Generics Sales Price by Type (2027-2032) & (US$/Unit) Table 116. Europe Osimertinib Generics Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Osimertinib Generics Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Osimertinib Generics Sales by Application (2021-2026) & (K Units) Table 119. Europe Osimertinib Generics Sales by Application (2027-2032) & (K Units) Table 120. Europe Osimertinib Generics Sales Price by Application (2021-2026) & (US$/Unit) Table 121. Europe Osimertinib Generics Sales Price by Application (2027-2032) & (US$/Unit) Table 122. Europe Osimertinib Generics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Osimertinib Generics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Osimertinib Generics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Osimertinib Generics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 126. Europe Osimertinib Generics Sales by Country (2021-2026) & (K Units) Table 127. Europe Osimertinib Generics Sales by Country (2027-2032) & (K Units) Table 128. Europe Osimertinib Generics Sales Price by Country (2021-2026) & (US$/Unit) Table 129. Europe Osimertinib Generics Sales Price by Country (2027-2032) & (US$/Unit) Table 130. Germany Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 131. France Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 132. U.K. Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 133. Italy Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 134. Russia Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 135. Spain Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 137. Switzerland Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 138. Sweden Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 139. Poland Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 140. China Osimertinib Generics Revenue by Type (2021-2026) & (US$ Million) Table 141. China Osimertinib Generics Revenue by Type (2027-2032) & (US$ Million) Table 142. China Osimertinib Generics Sales by Type (2021-2026) & (K Units) Table 143. China Osimertinib Generics Sales by Type (2027-2032) & (K Units) Table 144. China Osimertinib Generics Sales Price by Type (2021-2026) & (US$/Unit) Table 145. China Osimertinib Generics Sales Price by Type (2027-2032) & (US$/Unit) Table 146. China Osimertinib Generics Revenue by Application (2021-2026) & (US$ Million) Table 147. China Osimertinib Generics Revenue by Application (2027-2032) & (US$ Million) Table 148. China Osimertinib Generics Sales by Application (2021-2026) & (K Units) Table 149. China Osimertinib Generics Sales by Application (2027-2032) & (K Units) Table 150. China Osimertinib Generics Sales Price by Application (2021-2026) & (US$/Unit) Table 151. China Osimertinib Generics Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Asia Osimertinib Generics Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Osimertinib Generics Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Osimertinib Generics Sales by Type (2021-2026) & (K Units) Table 155. Asia Osimertinib Generics Sales by Type (2027-2032) & (K Units) Table 156. Asia Osimertinib Generics Sales Price by Type (2021-2026) & (US$/Unit) Table 157. Asia Osimertinib Generics Sales Price by Type (2027-2032) & (US$/Unit) Table 158. Asia Osimertinib Generics Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Osimertinib Generics Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Osimertinib Generics Sales by Application (2021-2026) & (K Units) Table 161. Asia Osimertinib Generics Sales by Application (2027-2032) & (K Units) Table 162. Asia Osimertinib Generics Sales Price by Application (2021-2026) & (US$/Unit) Table 163. Asia Osimertinib Generics Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Asia Osimertinib Generics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Osimertinib Generics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Osimertinib Generics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Osimertinib Generics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. Asia Osimertinib Generics Sales by Country (2021-2026) & (K Units) Table 169. Asia Osimertinib Generics Sales by Country (2027-2032) & (K Units) Table 170. Asia Osimertinib Generics Sales Price by Country (2021-2026) & (US$/Unit) Table 171. Asia Osimertinib Generics Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Japan Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 173. South Korea Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 174. India Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 175. Australia Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 176. Taiwan Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Osimertinib Generics Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Osimertinib Generics Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Osimertinib Generics Sales by Type (2021-2026) & (K Units) Table 181. SAMEA Osimertinib Generics Sales by Type (2027-2032) & (K Units) Table 182. SAMEA Osimertinib Generics Sales Price by Type (2021-2026) & (US$/Unit) Table 183. SAMEA Osimertinib Generics Sales Price by Type (2027-2032) & (US$/Unit) Table 184. SAMEA Osimertinib Generics Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Osimertinib Generics Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Osimertinib Generics Sales by Application (2021-2026) & (K Units) Table 187. SAMEA Osimertinib Generics Sales by Application (2027-2032) & (K Units) Table 188. SAMEA Osimertinib Generics Sales Price by Application (2021-2026) & (US$/Unit) Table 189. SAMEA Osimertinib Generics Sales Price by Application (2027-2032) & (US$/Unit) Table 190. SAMEA Osimertinib Generics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Osimertinib Generics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Osimertinib Generics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Osimertinib Generics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 194. SAMEA Osimertinib Generics Sales by Country (2021-2026) & (K Units) Table 195. SAMEA Osimertinib Generics Sales by Country (2027-2032) & (K Units) Table 196. SAMEA Osimertinib Generics Sales Price by Country (2021-2026) & (US$/Unit) Table 197. SAMEA Osimertinib Generics Sales Price by Country (2027-2032) & (US$/Unit) Table 198. Brazil Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 199. Argentina Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 200. Chile Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 201. Colombia Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 202. Peru Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 204. Israel Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 205. UAE Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 206. Turkey Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 207. Iran Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 208. Egypt Osimertinib Generics Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Osimertinib Generics Distributors List Table 212. Osimertinib Generics Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Osimertinib Generics Image Figure 2. Global Osimertinib Generics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Osimertinib Generics Market Size Share 2021 VS 2025 VS 2032 Figure 4. 40mg per Tablet Image Figure 5. 80mg per Tablet Image Figure 6. Global Osimertinib Generics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Osimertinib Generics Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital and Clinic Image Figure 9. Retail Pharmacies Image Figure 10. Other Image Figure 11. Global Osimertinib Generics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Osimertinib Generics Revenue (2021-2032) & (US$ Million) Figure 13. Global Osimertinib Generics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Osimertinib Generics Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Osimertinib Generics Revenue Market Share by Region (2021-2032) Figure 16. Global Osimertinib Generics Sales (2021-2032) & (K Units) Figure 17. Global Osimertinib Generics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Osimertinib Generics Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Osimertinib Generics Sales YoY (2021-2032) & (K Units) Figure 20. Europe Osimertinib Generics Sales YoY (2021-2032) & (K Units) Figure 21. China Osimertinib Generics Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Osimertinib Generics Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Osimertinib Generics Sales YoY (2021-2032) & (K Units) Figure 24. Global Osimertinib Generics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Osimertinib Generics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Osimertinib Generics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Osimertinib Generics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Osimertinib Generics Revenue Market Share by Type (2021-2032) Figure 30. Global Osimertinib Generics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Osimertinib Generics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Osimertinib Generics Sales Market Share by Type (2021-2032) Figure 33. Global Osimertinib Generics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Osimertinib Generics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Osimertinib Generics Revenue Market Share by Application (2021-2032) Figure 36. Global Osimertinib Generics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Osimertinib Generics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Osimertinib Generics Sales Market Share by Application (2021-2032) Figure 39. North America Osimertinib Generics Revenue Share by Type (2021-2032) Figure 40. North America Osimertinib Generics Sales Share by Type (2021-2032) Figure 41. North America Osimertinib Generics Revenue Share by Application (2021-2032) Figure 42. North America Osimertinib Generics Sales Share by Application (2021-2032) Figure 43. North America Osimertinib Generics Revenue Share by Country (2021-2032) Figure 44. North America Osimertinib Generics Sales Share by Country (2021-2032) Figure 45. Europe Osimertinib Generics Revenue Share by Type (2021-2032) Figure 46. Europe Osimertinib Generics Sales Share by Type (2021-2032) Figure 47. Europe Osimertinib Generics Revenue Share by Application (2021-2032) Figure 48. Europe Osimertinib Generics Sales Share by Application (2021-2032) Figure 49. Europe Osimertinib Generics Revenue Share by Country (2021-2032) Figure 50. Europe Osimertinib Generics Sales Share by Country (2021-2032) Figure 51. China Osimertinib Generics Revenue Share by Type (2021-2032) Figure 52. China Osimertinib Generics Sales Share by Type (2021-2032) Figure 53. China Osimertinib Generics Revenue Share by Application (2021-2032) Figure 54. China Osimertinib Generics Sales Share by Application (2021-2032) Figure 55. Asia Osimertinib Generics Revenue Share by Type (2021-2032) Figure 56. Asia Osimertinib Generics Sales Share by Type (2021-2032) Figure 57. Asia Osimertinib Generics Revenue Share by Application (2021-2032) Figure 58. Asia Osimertinib Generics Sales Share by Application (2021-2032) Figure 59. Asia Osimertinib Generics Revenue Share by Country (2021-2032) Figure 60. Asia Osimertinib Generics Sales Share by Country (2021-2032) Figure 61. SAMEA Osimertinib Generics Revenue Share by Type (2021-2032) Figure 62. SAMEA Osimertinib Generics Sales Share by Type (2021-2032) Figure 63. SAMEA Osimertinib Generics Revenue Share by Application (2021-2032) Figure 64. SAMEA Osimertinib Generics Sales Share by Application (2021-2032) Figure 65. SAMEA Osimertinib Generics Revenue Share by Country (2021-2032) Figure 66. SAMEA Osimertinib Generics Sales Share by Country (2021-2032) Figure 67. Osimertinib Generics Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Osimertinib Generics Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg per Tablet
  • 80mg per Tablet
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Beacon
  • Drug International
  • General Pharmaceuticals
  • Pharmacil
  • Zydus
  • Wanbang Biopharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Osimertinib Generics Market by Type
  3. 1.2.1 Global Osimertinib Generics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 40mg per Tablet
  5. 1.2.3 80mg per Tablet
  6. 1.3 Osimertinib Generics Market by Application
  7. 1.3.1 Global Osimertinib Generics Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital and Clinic
  9. 1.3.3 Retail Pharmacies
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Osimertinib Generics Market Dynamics
  1. 2.1 Osimertinib Generics Industry Trends
  2. 2.2 Osimertinib Generics Industry Drivers
  3. 2.3 Osimertinib Generics Industry Opportunities and Challenges
  4. 2.4 Osimertinib Generics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Osimertinib Generics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Osimertinib Generics Revenue by Region
  3. 3.2.1 Global Osimertinib Generics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Osimertinib Generics Revenue by Region (2021-2026)
  5. 3.2.3 Global Osimertinib Generics Revenue by Region (2027-2032)
  6. 3.2.4 Global Osimertinib Generics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Osimertinib Generics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Osimertinib Generics Sales by Region
  9. 3.4.1 Global Osimertinib Generics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Osimertinib Generics Sales by Region (2021-2026)
  11. 3.4.3 Global Osimertinib Generics Sales by Region (2027-2032)
  12. 3.4.4 Global Osimertinib Generics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Osimertinib Generics Revenue by Manufacturers
  2. 4.1.1 Global Osimertinib Generics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Osimertinib Generics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Osimertinib Generics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Osimertinib Generics Sales by Manufacturers
  6. 4.2.1 Global Osimertinib Generics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Osimertinib Generics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Osimertinib Generics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Osimertinib Generics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Osimertinib Generics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Osimertinib Generics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Osimertinib Generics Manufacturers, Product Type & Application
  13. 4.7 Global Osimertinib Generics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Osimertinib Generics Market CR5 and HHI
  16. 4.8.2 2025 Osimertinib Generics Tier 1, Tier 2, and Tier 3
5 Osimertinib Generics Market by Type
  1. 5.1 Global Osimertinib Generics Revenue by Type
  2. 5.1.1 Global Osimertinib Generics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Osimertinib Generics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Osimertinib Generics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Osimertinib Generics Sales by Type
  6. 5.2.1 Global Osimertinib Generics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Osimertinib Generics Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Osimertinib Generics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Osimertinib Generics Price by Type
6 Osimertinib Generics Market by Application
  1. 6.1 Global Osimertinib Generics Revenue by Application
  2. 6.1.1 Global Osimertinib Generics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Osimertinib Generics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Osimertinib Generics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Osimertinib Generics Sales by Application
  6. 6.2.1 Global Osimertinib Generics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Osimertinib Generics Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Osimertinib Generics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Osimertinib Generics Price by Application
7 Company Profiles
  1. 7.1 Beacon
  2. 7.1.1 Beacon Company Information
  3. 7.1.2 Beacon Business Overview
  4. 7.1.3 Beacon Osimertinib Generics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Beacon Osimertinib Generics Product Portfolio
  6. 7.1.5 Beacon Recent Developments
  7. 7.2 Drug International
  8. 7.2.1 Drug International Company Information
  9. 7.2.2 Drug International Business Overview
  10. 7.2.3 Drug International Osimertinib Generics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Drug International Osimertinib Generics Product Portfolio
  12. 7.2.5 Drug International Recent Developments
  13. 7.3 General Pharmaceuticals
  14. 7.3.1 General Pharmaceuticals Company Information
  15. 7.3.2 General Pharmaceuticals Business Overview
  16. 7.3.3 General Pharmaceuticals Osimertinib Generics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 General Pharmaceuticals Osimertinib Generics Product Portfolio
  18. 7.3.5 General Pharmaceuticals Recent Developments
  19. 7.4 Pharmacil
  20. 7.4.1 Pharmacil Company Information
  21. 7.4.2 Pharmacil Business Overview
  22. 7.4.3 Pharmacil Osimertinib Generics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pharmacil Osimertinib Generics Product Portfolio
  24. 7.4.5 Pharmacil Recent Developments
  25. 7.5 Zydus
  26. 7.5.1 Zydus Company Information
  27. 7.5.2 Zydus Business Overview
  28. 7.5.3 Zydus Osimertinib Generics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Zydus Osimertinib Generics Product Portfolio
  30. 7.5.5 Zydus Recent Developments
  31. 7.6 Wanbang Biopharmaceuticals
  32. 7.6.1 Wanbang Biopharmaceuticals Company Information
  33. 7.6.2 Wanbang Biopharmaceuticals Business Overview
  34. 7.6.3 Wanbang Biopharmaceuticals Osimertinib Generics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Wanbang Biopharmaceuticals Osimertinib Generics Product Portfolio
  36. 7.6.5 Wanbang Biopharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Osimertinib Generics Market Size by Type
  2. 8.1.1 North America Osimertinib Generics Revenue by Type (2021-2032)
  3. 8.1.2 North America Osimertinib Generics Sales by Type (2021-2032)
  4. 8.1.3 North America Osimertinib Generics Price by Type (2021-2032)
  5. 8.2 North America Osimertinib Generics Market Size by Application
  6. 8.2.1 North America Osimertinib Generics Revenue by Application (2021-2032)
  7. 8.2.2 North America Osimertinib Generics Sales by Application (2021-2032)
  8. 8.2.3 North America Osimertinib Generics Price by Application (2021-2032)
  9. 8.3 North America Osimertinib Generics Market Size by Country
  10. 8.3.1 North America Osimertinib Generics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Osimertinib Generics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Osimertinib Generics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Osimertinib Generics Market Size by Type
  2. 9.1.1 Europe Osimertinib Generics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Osimertinib Generics Sales by Type (2021-2032)
  4. 9.1.3 Europe Osimertinib Generics Price by Type (2021-2032)
  5. 9.2 Europe Osimertinib Generics Market Size by Application
  6. 9.2.1 Europe Osimertinib Generics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Osimertinib Generics Sales by Application (2021-2032)
  8. 9.2.3 Europe Osimertinib Generics Price by Application (2021-2032)
  9. 9.3 Europe Osimertinib Generics Market Size by Country
  10. 9.3.1 Europe Osimertinib Generics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Osimertinib Generics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Osimertinib Generics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Osimertinib Generics Market Size by Type
  2. 10.1.1 China Osimertinib Generics Revenue by Type (2021-2032)
  3. 10.1.2 China Osimertinib Generics Sales by Type (2021-2032)
  4. 10.1.3 China Osimertinib Generics Price by Type (2021-2032)
  5. 10.2 China Osimertinib Generics Market Size by Application
  6. 10.2.1 China Osimertinib Generics Revenue by Application (2021-2032)
  7. 10.2.2 China Osimertinib Generics Sales by Application (2021-2032)
  8. 10.2.3 China Osimertinib Generics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Osimertinib Generics Market Size by Type
  2. 11.1.1 Asia Osimertinib Generics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Osimertinib Generics Sales by Type (2021-2032)
  4. 11.1.3 Asia Osimertinib Generics Price by Type (2021-2032)
  5. 11.2 Asia Osimertinib Generics Market Size by Application
  6. 11.2.1 Asia Osimertinib Generics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Osimertinib Generics Sales by Application (2021-2032)
  8. 11.2.3 Asia Osimertinib Generics Price by Application (2021-2032)
  9. 11.3 Asia Osimertinib Generics Market Size by Country
  10. 11.3.1 Asia Osimertinib Generics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Osimertinib Generics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Osimertinib Generics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Osimertinib Generics Market Size by Type
  2. 12.1.1 SAMEA Osimertinib Generics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Osimertinib Generics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Osimertinib Generics Price by Type (2021-2032)
  5. 12.2 SAMEA Osimertinib Generics Market Size by Application
  6. 12.2.1 SAMEA Osimertinib Generics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Osimertinib Generics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Osimertinib Generics Price by Application (2021-2032)
  9. 12.3 SAMEA Osimertinib Generics Market Size by Country
  10. 12.3.1 SAMEA Osimertinib Generics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Osimertinib Generics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Osimertinib Generics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Osimertinib Generics Value Chain Analysis
  2. 13.1.1 Osimertinib Generics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Osimertinib Generics Production Mode & Process
  6. 13.2 Osimertinib Generics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Osimertinib Generics Distributors
  9. 13.2.3 Osimertinib Generics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst